Senti Biosciences CFO Resigns, Transitions to Consultancy Role
Company Announcements

Senti Biosciences CFO Resigns, Transitions to Consultancy Role

An update from Senti Biosciences (SNTI) is now available.

Deborah Knobelman, Ph.D., has decided to step down as CFO, Treasurer, and Head of Corporate Development at Senti Biosciences, effective May 3, 2024. Her resignation is not due to any dispute with the company’s practices. Following her departure, she’ll transition to a consultancy role to assist with a smooth handover of her duties, for which she’ll receive up to $60,000. Meanwhile, Senti Biosciences is actively seeking an interim CFO and Treasurer to fill the vacancy.

For an in-depth examination of SNTI stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlySenti Bio announces execution of grant award from CIRM for developing SENTI-202
TheFlySenti Biosciences Inc trading halted, news pending
TheFlySenti Bio announces 1-for-10 reverse stock split
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App